View this email in your browser

With New Pricing Law, the Feds Can Make Drug Firms Offers They Really Can't Refuse


By Mark Hemingway, RealClearInvestigations 
December 27, 2022

In RealClearInvestigations, Mark Hemingway reports on new federal drug-pricing legislation that critics are calling an unprecedented federal power grab — more akin to price-fixing than negotiation.

Read the Full Article →


If you are a member of the media, please note that this and all other original articles created by RealClearInvestigations may be republished for free with attribution. Attribution to RealClearInvestigations can be added to the author's byline, or noted at the beginning or end of the republished article. (These terms do not apply to outside articles linked on the site, nor to any images or photos that appear with the article.)
 
Twitter
Facebook
Website
Copyright © 2022 RealClearHoldings, All rights reserved.
You are receiving this email because you signed up to one of RCMG newsletters.

Our mailing address is:
RealClearHoldings
666 Dundee Rd Ste 600
Northbrook, IL 60062-2733

Add us to your address book


Want to change how you receive these emails?
You can update your preferences or unsubscribe from this list.

Email Marketing Powered by Mailchimp